SCHEMBL5229246

SCHEMBL5229246

O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(Cl)cc2)s1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
CES1 P23141 1/20 0.51
MAPT P10636 4/20 0.45
GABRA1 P14867 1/20 0.44
TP53 P04637 1/20 0.43
ALDH1A1 P00352 2/20 0.42
PRMT1 Q99873 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LMNA P02545 1/20 0.42
IDH1 O75874 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PGR P06401 1/20 0.40
DRD2 P14416 1/20 0.40
HTR2C P28335 1/20 0.40
DRD3 P35462 1/20 0.40
HTR6 P50406 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5231184 0.78 MAPT (0.68) MEN1KMT2ACES1MAPTGABRA1
SCHEMBL5237280 0.77 CES1 (0.49) MEN1KMT2ACES1MAPTALDH1A1
SCHEMBL5230722 0.75 MAPT (0.69) MEN1KMT2ACES1MAPTTP53
SCHEMBL5228629 0.75 IDH1 (0.51) MEN1KMT2ACES1MAPTALDH1A1
SCHEMBL5230316 0.74 CES1 (0.49) MEN1KMT2ACES1MAPTIDH1
SCHEMBL5230286 0.73 IDH1 (0.48) MEN1KMT2ACES1MAPTTP53
SCHEMBL17154 0.72 KMT2A (0.40) MEN1KMT2AMAPTALDH1A1TDP1
SCHEMBL5230151 0.72 CES1 (0.73) MEN1KMT2ACES1MAPTALDH1A1
SCHEMBL641243 0.72 SMN1; SMN2 (0.64) MEN1KMT2ACES1ALDH1A1IDH1
SCHEMBL23092462 0.71 GAA (0.39) MEN1KMT2AMAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519932-B1 BISARYLSULFONAMIDE COMPOUNDS AND THEIR USE IN CANCER THERAPY CYCLACEL LTD (GB) 2007-10-03 EP claimed